Karla R. Wiehagen

Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden

Meredith L. Stone, Katherine B. Chiappinelli, Huili Li et al. · Proceedings of the National Academy of Sciences · 2017 · 273 citations · Full text

Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity

Karla R. Wiehagen, Natasha Girgis, Douglas H. Yamada et al. · Cancer Immunology Research · 2017 · 159 citations · Full text

Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development

Xiaoming Feng, Gregory C. Ippolito, Lifeng Tian et al. · Blood · 2009 · 132 citations · Full text

DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer

Meghan Travers, Stephen M. Brown, Matthew Dunworth et al. · Cancer Research · 2019 · 110 citations · Full text

Foxp4 Is Dispensable for T Cell Development, but Required for Robust Recall Responses

Karla R. Wiehagen, Evann Corbo‐Rodgers, Shanru Li et al. · PLoS ONE · 2012 · 42 citations · Full text

Lymphocyte Development, T-regulatory Cell, Immunology +21